Ophthalmologists Welcome Genentech's Vabysmo, Though Overthrowing Regeneron's Eylea Will Be No Small Feat, Spherix Reports
/PRNewswire/ -- Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular...